Siegfried G Priglinger Selected Research

Proliferative Vitreoretinopathy

1/2020	3D Heads-Up Display vs. Standard Operating Microscope Vitrectomy for Rhegmatogenous Retinal Detachment.
1/2019	Comparison of Surgically Excised Premacular Membranes in Eyes with Macular Pucker and Proliferative Vitreoretinopathy.
1/2016	Epithelial-to-Mesenchymal Transition of RPE Cells In Vitro Confers Increased β1,6-N-Glycosylation and Increased Susceptibility to Galectin-3 Binding.
3/2011	Negative regulation of RPE cell attachment by carbohydrate-dependent cell surface binding of galectin-3 and inhibition of the ERK-MAPK pathway.
10/2009	Inhibition of human retinal pigment epithelial cell attachment, spreading, and migration by the human lectin galectin-1.
11/2006	Keratinocyte transglutaminase in proliferative vitreoretinopathy.
1/2006	Galectin-1 influences migration of retinal pigment epithelial cells.
10/2005	Pulsed electron avalanche knife in vitreoretinal surgery.
3/2004	TGF-beta2-induced cell surface tissue transglutaminase increases adhesion and migration of RPE cells on fibronectin through the gelatin-binding domain.
8/2003	Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Siegfried G Priglinger Research Topics

Disease

12	Retinal Perforations 09/2022 - 01/2006
12	Epiretinal Membrane (Epiretinal Membranes) 03/2022 - 08/2004
11	Proliferative Vitreoretinopathy 01/2020 - 01/2003
10	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 11/2002
10	Macular Edema 01/2022 - 10/2003
7	Retinal Detachment (Retinal Detachments) 09/2022 - 09/2006
7	Cataract (Cataracts) 05/2022 - 12/2007
6	Capsule Opacification 03/2021 - 07/2007
4	Fibrosis (Cirrhosis) 09/2018 - 10/2005
4	Cicatrix (Scar) 07/2007 - 01/2004
3	Melanoma (Melanoma, Malignant) 01/2022 - 08/2019
3	Choroidal Neovascularization 01/2022 - 05/2020
3	Glaucoma 09/2020 - 09/2006
3	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2008 - 10/2003
2	Neoplasms (Cancer) 01/2022 - 01/2020
2	Central Serous Chorioretinopathy 11/2021 - 05/2020
2	Atrophy 01/2021 - 01/2020
2	Presbyopia 01/2020 - 05/2018
2	Retinal Vein Occlusion 01/2015 - 10/2007
1	Astigmatism 05/2022
1	Aneurysm (Aneurysms) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Rupture 01/2022
1	Infections 12/2021
1	Disease Progression 08/2021
1	Retinal Diseases 08/2021
1	Geographic Atrophy 01/2021
1	Color Vision Defects (Color Blindness) 01/2021
1	Ganglion Cysts (Ganglion) 11/2020
1	Wounds and Injuries (Trauma) 09/2020
1	Fuchs' Endothelial Dystrophy 09/2020
1	Gliosis 01/2020
1	Optic Disk Drusen (Optic Disc Drusen) 01/2020
1	Anisometropia 11/2019
1	Pain (Aches) 09/2019
1	Edema (Dropsy) 06/2019
1	Inflammation (Inflammations) 06/2018

Drug/Important Bio-Agent (IBA)

11	Retinaldehyde (Retinal)IBA 01/2022 - 10/2003
8	Retinal Pigments (Pigments, Visual)IBA 01/2016 - 11/2002
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2019
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2005
4	Capsules (Microcapsules)IBA 09/2022 - 09/2005
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 01/2006
4	Fibronectins (Fibronectin)IBA 03/2011 - 03/2004
3	Messenger RNA (mRNA)IBA 01/2020 - 09/2006
3	CollagenIBA 03/2018 - 01/2004
3	Trypan Blue FDA Link 04/2013 - 08/2004
3	Bromphenol Blue (Bromophenol Blue)IBA 05/2009 - 12/2007
3	Coloring Agents (Dyes)IBA 02/2008 - 09/2005
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2022 - 02/2008
2	CateninsIBA 08/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 03/2021 - 12/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2020 - 09/2006
2	Ranibizumab (Lucentis)FDA Link 01/2018 - 01/2015
2	microplasminIBA 12/2017 - 11/2017
2	Bevacizumab (Avastin)FDA Link 11/2007 - 10/2007
2	TransglutaminasesIBA 11/2006 - 07/2005
2	epsilon-(gamma-glutamyl)-lysineIBA 09/2006 - 07/2005
1	Silicone OilsIBA 09/2022
1	fluocinoloneIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 03/2021
1	Gefitinib (Iressa)FDA Link 03/2021
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2021
1	AntigensIBA 11/2020
1	Nerve Growth Factors (Neurotrophins)IBA 11/2020
1	SteroidsIBA 03/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2020
1	2,4- diamino- 5- cyclohexyl- 6- methylpyrimidineIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	N-Methylaspartate (NMDA)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2019
1	trametinibIBA 08/2019
1	dabrafenibIBA 08/2019
1	Inosine Monophosphate (IMP)IBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2018
1	N 30IBA 01/2015

Therapy/Procedure

14	Vitrectomy 09/2022 - 09/2006
10	Lasers (Laser) 11/2021 - 10/2003
8	Traction 06/2019 - 06/2011
7	Intraocular Lenses (Intraocular Lens) 05/2022 - 01/2012
6	Therapeutics 01/2022 - 01/2018
4	Intravitreal Injections 12/2017 - 10/2007
3	Laser In Situ Keratomileusis (LASIK) 09/2019 - 07/2005
2	Brachytherapy 01/2022 - 11/2021
2	Phacoemulsification 01/2020 - 06/2018
2	Vitreoretinal Surgery 01/2020 - 10/2005
2	Injections 01/2018 - 10/2007
1	Aftercare (After-Treatment) 01/2022
1	Critical Care (Surgical Intensive Care) 12/2021
1	Laser Therapy (Surgery, Laser) 11/2021
1	Proton Therapy 11/2021
1	Radiotherapy 01/2021
1	Excimer Lasers 09/2020
1	Telescopes 11/2019
1	Free Tissue Flaps 09/2019
1	Cataract Extraction 06/2018
1	Refractive Surgical Procedures 05/2018
1	Light Coagulation 01/2018